Institutional Biosafety Committee

An Institutional Biosafety Committee (IBC) is required at institutions that receive funding from the National Institutes of Health (NIH) for research involving recombinant DNA molecules. The purpose of the Institutional Biosafety Committee (IBC) is to ensure the protection of faculty, staff, students and residents within the University environment who generate, process, and dispose of potentially hazardous biological materials at Wake Forest University (WFU).  All recombinant DNA/synthetic nucleic acid research at Wake Forest University (WFU) regardless of funding source, must be conducted in accordance with the NIH Guidelines for Research Involving Recombinant DNA Molecules and must be registered with the WFU, Reynolda Campus IBC using the WFU IBC Application. The IBC works in conjunction with Environmental Health & Safety Department to establish, monitor, and enforce policies or procedures for work with biohazardous materials.

The IBC meets four times a year, for review and approval of protocols and to discuss other business relevant to the charter of the IBC.

WFU IBC AUTHORITY STATEMENT